Related Experiment Videos
New approaches to intravesical chemo-immunotherapy in superficial bladder cancer
1Department of Urology, Bosch Medical Center, Hertogenbosch, The Netherland.
Progress in Clinical and Biological Research
|January 1, 1992
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Practical aspects of clinical trials on chemoprevention of prostate cancer.
European urology·1999
Management of carcinoma of the bladder.
American journal of clinical oncology·1998
DNA homology and chromosome stability: a sensitive yeast genetic system for identifying double-stranded DNA damage.
Progress in clinical and biological research·2018
Interaction of lipopolysaccharide with a mammalian lyso-phosphatidate acyltransferase (LPAAT) transfected into E. coli, and effect of lisofylline on LPAAT transfected into mammalian cells.
Progress in clinical and biological research·1998
The molecular basis for therapeutic concepts utilizing CD14.
Progress in clinical and biological research·1998
Endotoxin tolerance alters macrophage membrane regulatory G proteins.
Progress in clinical and biological research·1998
Molecular mechanisms responsible for endotoxin tolerance.
Progress in clinical and biological research·1998
Antibiotic-mediated release of endotoxin and the pathogenesis of gram-negative sepsis.
Progress in clinical and biological research·1998
An ulcerated ileal leiomyosarcoma identified by single-balloon enteroscopy despite nondiagnostic mucosal biopsies.
Revista espanola de enfermedades digestivas·2026
Rectal tonsil mimicking a rectal neuroendocrine tumor.
Revista espanola de enfermedades digestivas·2026
Assessment of Clinical and Immunological Factors of Local Recurrence in Canine Soft Tissue Sarcoma.
Veterinary and comparative oncology·2026
Tanshinone IIA restores CD8+ T-cell immunity in TNBC by suppressing the IDO1-kynurenine axis.
Frontiers in pharmacology·2026
A hypothesis and evidence map for neuroimmune regulation of DOCK-family cytoskeletal programs in solid tumors.
Frontiers in immunology·2026